Status:
COMPLETED
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Helicobacter Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Up to now, to our knowledge, there is few randomized, large scale study prospectively and simultaneously comparing the efficacy, adverse effects and patient adherence of these current recommended 1st-...
Detailed Description
Patients having H. pylori-positive chronic gastritis with/without peptic ulcers will be recruited. All undergo endoscopy with biopsy before treatment. Four to eight weeks after termination of treatmen...
Eligibility Criteria
Inclusion
- patients having H. pylori related chronic gastritis with/without peptic ulcers who are aged greater than 18 years and are willing to received eradication therapy.
Exclusion
- pregnant or nursing woman
- serious concomitant illness and malignant tumor of any kind
- history of hypersensitivity to test drugs
- serious bleeding during the course of this ulcer
- previous gastric surgery
- receiving bismuth salts, proton pump inhibitors, or antibiotics in the previous month.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
618 Patients enrolled
Trial Details
Trial ID
NCT01163435
Start Date
August 1 2010
End Date
October 1 2013
Last Update
December 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10043